Arkolith/Insider Trading/BEAM/Form 4

Bellon Christine

Chief Legal OfficerBeam Therapeutics Inc. (BEAM) · full profile →Form 4 · filed Jan 20, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$645K
Net Open-Market Flow
-$645K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 15, 2026Sell(S)16K$34.72$554K98K
Jan 15, 2026Sell(S)2K$33.62$71K114K
Jan 15, 2026Sell(S)559$35.40$20K97K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-016552) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML